178 related articles for article (PubMed ID: 16447132)
1. Establishing government-operated vaccine programs: an industry perspective.
Paradiso PR
Clin Infect Dis; 2006 Mar; 42 Suppl 3():S118-20. PubMed ID: 16447132
[TBL] [Abstract][Full Text] [Related]
2. Strengthening the supply of routinely recommended vaccines in the United States: a perspective from the American Medical Association.
Tan L;
Clin Infect Dis; 2006 Mar; 42 Suppl 3():S121-4. PubMed ID: 16447133
[TBL] [Abstract][Full Text] [Related]
3. The United States pediatric vaccine stockpile program.
Lane KS; Chu SY; Santoli JM
Clin Infect Dis; 2006 Mar; 42 Suppl 3():S125-9. PubMed ID: 16447134
[TBL] [Abstract][Full Text] [Related]
4. Vaccine manufacturing: challenges and solutions.
Ulmer JB; Valley U; Rappuoli R
Nat Biotechnol; 2006 Nov; 24(11):1377-83. PubMed ID: 17093488
[TBL] [Abstract][Full Text] [Related]
5. Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugs.
Noah L
S C Law Rev; 2002; 54(2):371-403. PubMed ID: 15156891
[TBL] [Abstract][Full Text] [Related]
6. Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences.
Shrestha SS; Wallace GS; Meltzer MI
Vaccine; 2010 Aug; 28(38):6318-32. PubMed ID: 20638451
[TBL] [Abstract][Full Text] [Related]
7. Strengthening the supply of routinely administered vaccines in the United States: problems and proposed solutions.
Klein JO; Myers MG
Clin Infect Dis; 2006 Mar; 42 Suppl 3():S97-103. PubMed ID: 16447139
[TBL] [Abstract][Full Text] [Related]
8. Vaccine shortages: history, impact, and prospects for the future.
Hinman AR; Orenstein WA; Santoli JM; Rodewald LE; Cochi SL
Annu Rev Public Health; 2006; 27():235-59. PubMed ID: 16533116
[TBL] [Abstract][Full Text] [Related]
9. Vaccine shortages eliminate possibility for excess capacity in stockpiles.
Congeni BL
Pediatr Ann; 2004 Sep; 33(9):577-83. PubMed ID: 15462572
[TBL] [Abstract][Full Text] [Related]
10. Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention.
Rodewald LE; Orenstein WA; Mason DD; Cochi SL
Clin Infect Dis; 2006 Mar; 42 Suppl 3():S104-10. PubMed ID: 16447130
[TBL] [Abstract][Full Text] [Related]
11. Vaccine supply, demand, and policy: a primer.
Muzumdar JM; Cline RR
J Am Pharm Assoc (2003); 2009; 49(4):e87-99. PubMed ID: 19589753
[TBL] [Abstract][Full Text] [Related]
12. The U.S. vaccine supply.
Hinman AR
N Engl J Med; 2005 Mar; 352(10):1046-7; author reply 1046-7. PubMed ID: 15758020
[No Abstract] [Full Text] [Related]
13. Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee.
Santoli JM; Peter G; Arvin AM; Davis JP; Decker MD; Fast P; Guerra FA; Helms CM; Hinman AR; Katz R; Klein JO; Koslap-Petraco MB; Paradiso PR; Schaffner W; Whitley-Williams PN; Williamson DE; Gellin B;
JAMA; 2003 Dec; 290(23):3122-8. PubMed ID: 14679275
[TBL] [Abstract][Full Text] [Related]
14. Improving vaccine supply and development: who needs what?
Pauly MV
Health Aff (Millwood); 2005; 24(3):680-9. PubMed ID: 15886159
[TBL] [Abstract][Full Text] [Related]
15. Public vaccine manufacturing capacity in the Latin American and Caribbean region: current status and perspectives.
Cortes Mde L; Cardoso D; Fitzgerald J; DiFabio JL
Biologicals; 2012 Jan; 40(1):3-14. PubMed ID: 22033155
[TBL] [Abstract][Full Text] [Related]
16. The impact of globalization on vaccine development and availability.
Milstien JB; Kaddar M; Kieny MP
Health Aff (Millwood); 2006; 25(4):1061-9. PubMed ID: 16835187
[TBL] [Abstract][Full Text] [Related]
17. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.
Jadhav S; Datla M; Kreeftenberg H; Hendriks J
Vaccine; 2008 Mar; 26(13):1611-5. PubMed ID: 18294742
[TBL] [Abstract][Full Text] [Related]
18. Glovax's perspective: opportunities and approaches to vaccine business in Asia.
Shin SH
Dev Biol (Basel); 2002; 110():31-4. PubMed ID: 12477304
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting U.S. manufacturers' decisions to produce vaccines.
Coleman MS; Sangrujee N; Zhou F; Chu S
Health Aff (Millwood); 2005; 24(3):635-42. PubMed ID: 15886154
[TBL] [Abstract][Full Text] [Related]
20. Stockpile levels for pediatric vaccines: how much is enough?
Jacobson SH; Sewell EC; Proano RA; Jokela JA
Vaccine; 2006 Apr; 24(17):3530-7. PubMed ID: 16522344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
